Yin Wen-juan, Wu Mei-juan, Yang Hai-yan, Zhu Xiu, Sun Wen-yong
Pathological Department, Zhejiang Cancer Hospital, Hangzhou 310022, China.
Zhonghua Xue Ye Xue Za Zhi. 2013 May;34(5):377-82. doi: 10.3760/cma.j.issn.0253-2727.2013.05.001.
To investigate the clinicopathological features of primary gastrointestinal non-Hodgkin's lymphomas (PGI-NHL) and their prognostic values.
The clinical and pathological data of 216 patients diagnosed as PGI-NHL from Zhejiang Cancer Hospital were analyzed retrospectively. χ² test, log-liner model analysis, COX proportional hazard regression analysis and Life-table survival analysis were used to analyze the survival status of the patients by SAS 8.2 software, and Log-rank test was performed to couple the overall survival rates with different prognostic factors.
Totally, the age of onset was 8 to 89 years with the median age of 56.5 years. Male versus female was 1.27∶1(121∶95). The most frequently involved location was stomach (147 cases, 68.1%), followed by ileocecus (25 cases, 11.6%), large intestine (20 cases, 9.3%), small intestine (17 cases, 7.9%) and multiple GI involvement (5 cases, 2.3%). 182 cases were classified as B cell lymphomas, 22 cases as T cell lymphomas, and 12 cases not classified exactly due to insufficient data. The 3-year and 5-year survival rates of the patients were 69.4% and 53.3%, respectively. Univariate analysis revealed that age>60 years, ECOG≥2, high LDH level, stage Ⅲ-Ⅳ, IPI≥2, T cell type and intestinal involvement were predictors for poor prognosis. IPI≥2, T cell type and intestinal involvement were independent adverse predictors for prognosis by multiple COX proportional hazard regression analysis. Among different treatment groups, cases received chemotherapy combined with local radiotherapy gained the best survival status.
B-cell lymphoma was the main pathological type in PGI-NHL; IPI≥2, T-cell type and intestinal involvement are independent adverse predictors for prognosis; chemotherapy combined with local radiotherapy might be the choice of approach for advanced stage and aggressive PGI-HNL.
探讨原发性胃肠道非霍奇金淋巴瘤(PGI-NHL)的临床病理特征及其预后价值。
回顾性分析浙江省肿瘤医院确诊为PGI-NHL的216例患者的临床和病理资料。采用χ²检验、对数线性模型分析、COX比例风险回归分析和寿命表生存分析,通过SAS 8.2软件分析患者的生存状况,并进行Log-rank检验以比较不同预后因素的总生存率。
发病年龄8~89岁,中位年龄56.5岁。男女比例为1.27∶1(121∶95)。最常累及的部位是胃(147例,68.1%),其次是回盲部(25例,11.6%)、大肠(20例,9.3%)、小肠(17例,7.9%)和胃肠道多部位受累(5例,2.3%)。182例为B细胞淋巴瘤,22例为T细胞淋巴瘤,12例因资料不足未准确分类。患者的3年和5年生存率分别为69.4%和53.3%。单因素分析显示,年龄>60岁、ECOG≥2、乳酸脱氢酶(LDH)水平高、Ⅲ-Ⅳ期、国际预后指数(IPI)≥2、T细胞型和肠道受累是预后不良的预测因素。多因素COX比例风险回归分析显示,IPI≥2、T细胞型和肠道受累是独立的不良预后预测因素。在不同治疗组中,接受化疗联合局部放疗的患者生存状况最佳。
B细胞淋巴瘤是PGI-NHL的主要病理类型;IPI≥2、T细胞型和肠道受累是独立的不良预后预测因素;化疗联合局部放疗可能是晚期和侵袭性PGI-HNL的治疗方法选择。